This topic contains 0 replies, has 1 voice, and was last updated by 
-
Posts
-
The U.S. Food and Drug Administration has accepted Neurocrine Biosciences’ new drug application for opicapone as a potential add-on therapy for Parkinson’s. Read more here.
What do you think about this news?
You must be logged in to reply to this topic.
